Sort
25,944 grants matching “neurodegeneration”
Chemical Approaches to Understand the Roles of O-GlcNAc Glycosylation in Biology
$411,289Linda C Hsieh-Wilson · California Institute Of Technology · R01 · FY2015 · GM
Chemical Approaches to Understand the Roles of O-GlcNAc Glycosylation in Biology
$411,289Linda C Hsieh-Wilson · California Institute Of Technology · R01 · FY2016 · GM
A phase 2 study of a vitamin metabolite for PKAN
$411,268Penelope Hogarth · Oregon Health & Science University · R01 · FY2022 · HD
Microglia antigen presentation in the CNS of Alzheimer's disease
$411,250Wassim Elyaman · Columbia University Health Sciences · R01 · FY2023 · AG
METTL3-mediated regulation of motor neuron function
$411,250Francesco Lotti · Columbia University Health Sciences · R01 · FY2023 · AG
ER stress as the cause for dementia-associated olfactory dysfunction
$411,248Stavros Lomvardas · Columbia University Health Sciences · R01 · FY2023 · DC
Role of TFEB in Tauopathy
$411,224Hui Zheng · Baylor College Of Medicine · R01 · FY2016 · NS
Cell Signaling and Neurodegeneration
$411,171University Of Minnesota Twin Cities · R01 · FY2004 · NS
Creatine Safety, Tolerability, and Efficacy in Huntington's Disease: CREST-E
$411,170Steven M Hersch · Massachusetts General Hospital · U01 · FY2015 · AT
Calpain cleavage of α-synuclein and T-cell reactivity in Parkinsonâs disease
$411,125Azizul Haque · Medical University Of South Carolina · R21 · FY2020 · NS
Molecular Phenotyping of Cortical Cell Types in ALS-Related Neurodegeneration
$411,038Eric F Schmidt · Rockefeller University · R01 · FY2024 · NS
Decoding cerebrospinal fluid huntingtin biomarkers
$410,979Amber L Southwell · University Of Central Florida · R01 · FY2023 · NS
Capturing the molecular complexity of Alzheimer's disease through the lens of RNA binding proteins
$410,947Benjamin L Wolozin · Boston University Medical Campus · RF1 · FY2020 · AG
THE PERIPHERAL NERVOUS SYSTEM: A WINDOW INTO KRABBE DISEASE
$410,896Maria L Feltri · State University Of New York At Buffalo · R01 · FY2022 · NS
Characterization of Dystonia Gene and Protein
$410,875Massachusetts General Hospital · R01 · FY2004 · NS
Characterization of Dystonia Gene and Protein
$410,875Massachusetts General Hospital · R01 · FY2005 · NS
Characterization of Dystonia Gene and Protein
$410,875Massachusetts General Hospital · R01 · FY2003 · NS
Characterization of Dystonia Gene and Protein
$410,875Massachusetts General Hospital · R01 · FY2002 · NS
Decoding cerebrospinal fluid huntingtin biomarkers
$410,775Amber L Southwell · University Of Central Florida · R01 · FY2022 · NS
Lewy Body Dementia Biomarkers
$410,661Kirk A Frey · University Of Michigan At Ann Arbor · U01 · FY2019 · NS
Non-Invasive Markers of Neurodegeneration in Movement Disorders
$410,658David E Vaillancourt · University Of Florida · R01 · FY2021 · NS
Non-Invasive Markers of Neurodegeneration in Movement Disorders
$410,658David E Vaillancourt · University Of Florida · R01 · FY2020 · NS
Non-Invasive Markers of Neurodegeneration in Movement Disorders
$410,658David E Vaillancourt · University Of Florida · R01 · FY2018 · NS
Non-Invasive Markers of Neurodegeneration in Movement Disorders
$410,658David E Vaillancourt · University Of Florida · R01 · FY2019 · NS
Non-Invasive Markers of Neurodegeneration in Movement Disorders
$410,658David E Vaillancourt · University Of Florida · R01 · FY2022 · NS